1. Home
  2. TYRA vs WABC Comparison

TYRA vs WABC Comparison

Compare TYRA & WABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$37.96

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Westamerica Bancorporation

WABC

Westamerica Bancorporation

HOLD

Current Price

$49.95

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYRA
WABC
Founded
2018
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
TYRA
WABC
Price
$37.96
$49.95
Analyst Decision
Strong Buy
Hold
Analyst Count
9
2
Target Price
$44.63
$52.50
AVG Volume (30 Days)
1.1M
145.2K
Earning Date
03-02-2026
04-16-2026
Dividend Yield
N/A
3.69%
EPS Growth
N/A
N/A
EPS
N/A
3.40
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$14.69
Revenue Growth
N/A
N/A
52 Week Low
$6.42
$42.00
52 Week High
$38.53
$53.48

Technical Indicators

Market Signals
Indicator
TYRA
WABC
Relative Strength Index (RSI) 68.00 42.62
Support Level $30.10 $46.33
Resistance Level N/A $50.05
Average True Range (ATR) 2.31 1.15
MACD 0.24 -0.13
Stochastic Oscillator 92.17 50.64

Price Performance

Historical Comparison
TYRA
WABC

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About WABC Westamerica Bancorporation

Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California and all the way east to Nevada County.

Share on Social Networks: